newsfilter
← Latest News
PR Newswire·

Seqirus Begins Shipping Portfolio of Innovative Vaccines for the 2021/22 U.S. Influenza Season

SUMMIT, N.J., July 27, 2021 /PRNewswire/ -- Seqirus offers a differentiated portfolio of influenza vaccines, including FLUCELVAX® QUADRIVALENT (Influenza Vaccine), the first and only cell-based quadrivalent influenza vaccine for eligible persons two